Transfer of Interferon β-1a into Human Breastmilk
- 1 April 2012
- journal article
- research article
- Published by Mary Ann Liebert Inc in Breastfeeding Medicine
- Vol. 7 (2), 123-125
- https://doi.org/10.1089/bfm.2011.0044
Abstract
Aim: This study determined the transfer of intramuscular interferon β-1a into human milk and provides an estimate of infant exposure to this antiviral in six women chronically receiving intramuscular interferon β-1a (Avonex®, Biogen Idec, Research Triangle Park, NC). Methods: Interferon β-1a was measured at various times at steady state in milk samples collected from women receiving interferon β-1a at 30 μg/week. Results: Average milk concentrations were 46.7, 97.4, 66.4, 77.5, 103.1, 108.3, 124, and 87.9 pg/mL at 0, 1, 4, 8, 12, 24, 48, and 72 hours, respectively, after dosing. Using the highest value measured (179 pg/mL), the estimated relative infant dose would be 0.006% of the maternal dose. Conclusions: These data clearly suggest that interferon β-1a does not penetrate the milk compartment significantly and that levels in milk are far subclinical. No side effects were noted in any of the breastfed infants.Keywords
This publication has 5 references indexed in Scilit:
- Multiple SclerosisMedical Clinics of North America, 2009
- Complexation hydrogels for intestinal delivery of interferon β and calcitoninJournal of Controlled Release, 2009
- High-dose, high-frequency recombinant interferon beta-1a in the treatment of multiple sclerosisExpert Opinion on Pharmacotherapy, 2009
- Transfer of Interferon Alfa Into Human Breast MilkJournal of Human Lactation, 2000
- Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta‐1a after intramuscular and subcutaneous administrationEuropean Journal of Neurology, 1998